IXALTIS SA
DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS
2 employees · est. 2012 · Toulouse, France
ZYUS Life Sciences
Advancing the Science of Well-Being.
53 employees · est. 2018 · Saskatoon, Canada
IXALTIS SA is the older company (2012 vs 2018); ZYUS Life Sciences is the larger of the two.
Side-by-Side Comparison
| Metric | IXALTIS SA | ZYUS Life Sciences |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2018 |
| Headquarters | ||
| Headquarters | Toulouse, France | Saskatoon, Canada |
| Employees | ||
| Employees | 2 | 53 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $8.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Pharmaceuticals, Therapeutics, Genitourinary Disorders, Medical Need, Drug Development, Clinical Trials, Urology, Proprietary Position, Scientific Expertise, Clinical Stage Drugs | Cannabinoid-based Pharmaceuticals, Biopharmaceuticals, Phytotherapeutic Medical Solutions, Pain Management, Clinical Research, Regulatory Approval, Non-opioid-based Pharmaceuticals, Intellectual Property Protection, Quality In Manufacturing, Clinical Development, Patient Care, Pharmaceutical Manufacturing |
| Website | ||
| Website | ixaltis.com | zyus.com |
About IXALTIS SA
IXALTIS SA is a specialty pharmaceutical company that focuses on developing innovative treatments for genitourinary tract disorders. Founded in 2012 and headquartered in France, IXALTIS aims to address unmet medical needs in genitourinary (GU) disorders. The company has secured an exclusive worldwid...
About ZYUS Life Sciences
ZYUS Life Sciences is a Canadian life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Established in 2018, the company is listed on the TSXV as ZYUS. ZYUS is committed to advancing the science of well-be...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at IXALTIS SA and ZYUS Life Sciences — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at IXALTIS SA and ZYUS Life Sciences — by email.
Frequently Asked Questions
Compare IXALTIS SA with someone else
Start typing a company name or domain.